Avrio Biopharmaceuticals provides cGMP manufacturing services for a range of active pharmaceutical ingredients (APIs), including Gabapentin, Lyrica, Modafinil, and Prednisone. We specialize in the production of these compounds for clinical trial materials, ensuring consistent quality and adherence to regulatory requirements.